Wabash National Corp. (0LSO)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 12.92 |
|---|---|
| 52-week range | 6.65 – 14.37 |
| Return, 1 month / 3 months | +4.4% / −2.2% |
| Return, 1 year / 3 years | +49.5% / – |
| Trend | Uptrend |
| RSI (14) | 50 |
| Volatility (1 year) | 69.5% |
| Worst drawdown (1 year) | -43.4% |
| Average daily value traded | 0.01M USD |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wabash National designs and builds commercial truck trailers and truck bodies for freight haulers and logistics operators. Its range covers dry freight vans, refrigerated trailers, platform trailers and tank trailers, along with truck bodies and composite panels used in transportation equipment. The company is based in Lafayette, Indiana, in the United States, and serves customers across North America who move goods by road. Its engineered products also find use in other industrial applications beyond trailers.
The shares are listed on the London Exchange in UK under the code 0LSO, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wabash National Corp. (0LSO) trades on the London Exchange in UK. It last closed at USD 12.92 on 20 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 2,036 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 49.5% and over the last three months it fell 2.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 26.0% | ||
| From 52-week high | -10.1% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.2% | ||
| 6-month return | 67.2% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 69.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.4% | ||
| Liquidity | 10 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.4% |
|---|---|
| 1 month | +4.4% |
| 3 months | −2.2% |
| 6 months | +67.2% |
| 1 year | +49.5% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 12.79 / 10.25 |
|---|---|
| Golden / death cross (60 days) | Golden, 57 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Oct 2026 | USD 0.0800 |
| 1 Jul 2026 | USD 0.0800 |
| 1 Apr 2026 | USD 0.0800 |
| 8 Jan 2026 | USD 0.0800 |
| 2 Oct 2025 | USD 0.0800 |
| 2 Jul 2025 | USD 0.0800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.